Eagle Ridge Investment Management Has $8.50 Million Position in CME Group Inc (CME)

Eagle Ridge Investment Management trimmed its position in CME Group Inc (NASDAQ:CME) by 2.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 51,657 shares of the financial services provider’s stock after selling 1,420 shares during the quarter. CME Group accounts for approximately 1.2% of Eagle Ridge Investment Management’s holdings, making the stock its 29th biggest holding. Eagle Ridge Investment Management’s holdings in CME Group were worth $8,502,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Sheaff Brock Investment Advisors LLC grew its position in shares of CME Group by 0.3% in the 4th quarter. Sheaff Brock Investment Advisors LLC now owns 22,040 shares of the financial services provider’s stock worth $4,146,000 after buying an additional 60 shares during the period. Dorsey & Whitney Trust CO LLC boosted its stake in CME Group by 1.4% in the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 4,575 shares of the financial services provider’s stock worth $860,000 after purchasing an additional 65 shares in the last quarter. Dubuque Bank & Trust Co. boosted its stake in CME Group by 83.1% in the 1st quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 69 shares in the last quarter. Front Barnett Associates LLC boosted its stake in CME Group by 5.4% in the 4th quarter. Front Barnett Associates LLC now owns 1,433 shares of the financial services provider’s stock worth $267,000 after purchasing an additional 73 shares in the last quarter. Finally, Ascension Asset Management LLC boosted its stake in CME Group by 0.6% in the 4th quarter. Ascension Asset Management LLC now owns 12,385 shares of the financial services provider’s stock worth $2,330,000 after purchasing an additional 75 shares in the last quarter. 84.78% of the stock is currently owned by institutional investors.

In other news, Director Jeffrey M. Bernacchi sold 10,087 shares of the company’s stock in a transaction dated Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total transaction of $1,794,880.78. Following the completion of the sale, the director now owns 42,004 shares of the company’s stock, valued at approximately $7,474,191.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Ronald A. Pankau sold 200 shares of the company’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $182.90, for a total transaction of $36,580.00. Following the sale, the director now directly owns 3,600 shares of the company’s stock, valued at approximately $658,440. The disclosure for this sale can be found here. Insiders have sold a total of 38,489 shares of company stock valued at $6,739,196 in the last ninety days. Insiders own 1.20% of the company’s stock.

A number of brokerages recently issued reports on CME. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research note on Wednesday, April 17th. BidaskClub upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research note on Thursday, April 18th. ValuEngine upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. UBS Group lowered their target price on shares of CME Group from $179.00 to $175.00 and set a “neutral” rating on the stock in a research note on Thursday, May 2nd. Finally, Bank of America set a $180.00 target price on shares of CME Group and gave the company a “hold” rating in a research note on Tuesday, April 9th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company’s stock. CME Group presently has a consensus rating of “Hold” and an average price target of $189.71.

CME opened at $182.79 on Friday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.16. The stock has a market cap of $65.06 billion, a price-to-earnings ratio of 26.80, a P/E/G ratio of 4.16 and a beta of 0.32. CME Group Inc has a 52-week low of $157.21 and a 52-week high of $197.08.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.60 by $0.02. CME Group had a net margin of 42.47% and a return on equity of 9.29%. The business had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.19 billion. During the same quarter in the prior year, the business earned $1.86 EPS. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, analysts expect that CME Group Inc will post 6.62 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 10th will be given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.64%. The ex-dividend date of this dividend is Friday, June 7th. CME Group’s payout ratio is currently 43.99%.

ILLEGAL ACTIVITY WARNING: This report was originally reported by Stock Observer and is the property of of Stock Observer. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at https://www.thestockobserver.com/2019/05/17/eagle-ridge-investment-management-has-8-50-million-position-in-cme-group-inc-cme.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: Rule of 72

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.